Extragenital bowenoid papulosis associated with atypical human papillomavirus genotypes

Anthony J. Papadopoulos1, Robert A. Schwartz1, Aza Lefkowitz1, Lily L. Tinkle1, Camila K. Jänniger1, W. Clark Lambert1
1Dermatology, Pediatrics and Pathology, New Jersey Medical School, Newark, USA

Tóm tắt

Bowenoid papulosis typically appears as grouped violaceous or redbrown papules in the genital or perianal regions and clinically resembles condylomata acuminata. Isolated extragenital bowenoid papulosis is rare and has been reported in only a few case reports. A 51 -year-old immunocompetent, healthy woman had two solitary papules on the elbow; a 41-year-old HIV-positive man had a solitary cutaneous plaque on the abdomen. No genital, periungual, or other extragenital sites of involvement were noted in either patient. The diagnosis was confirmed histologically in both cases. Lesional skin from the female patient was tested with the Digenehybrid HPV DNA assay and was positive for a mixture of low-risk HPV subtypes (6, 11, 42, 43, 44). Lesional skin from the male patient was tested with polymerase chain reaction (PCR). Consensus primers targeted for the HPV L1 region, which is a highly conserved sequence common to more than 20 HPV subtypes encoding a viral capsid protein, were used. PCR using the consensus primers was positive, but type-specific probes for HPV types 6, 11, 16, 18, 45, 31, 33, 35, and 39 were negative. To our knowledge, our male patient represents the first case of isolated bowenoid papulosis of the abdominal skin. Isolated upper-extremity bowenoid papulosis in our female patient is also a unique case in both location and involvement of low-risk HPV types (6, 11, 42, 43, 44), which have not been previously associated with extragenital bowenoid papulosis.

Tài liệu tham khảo

Schwartz RA, Janniger CK. Bowenoid papulosis. J Am Acad Dermatol 1991; 24:261–264 Rogozinski TT, Janniger CK. Bowenoid papulosis. Am Fam Physician 1988; 38:161–164 Patterson JW, Kao GF, Graham JH, et al. Bowenoid papulosis. A clinicopathologic study with ultrastructural observations. Cancer 1986; 57:823–836 Fader DJ, Stoler MH, Anderson TF. Isolated extragenital HPV-thirties-group-positive bowenoid papulosis in an AIDS patient. Br J Dermatol 1994; 131:577–580 Johnson TM, Saluja A, Fader D, et al. Isolated extragenital bowenoid papulosis of the neck. J Am Acad Dermatol 1999; 41:867–870 Grob JJ, Zarour H, Jacquemier J, et al. Extra-anogenital HPV 16-related bowenoid papulosis. Genitourin Med 1991; 67:18–20 Baron JM, Rubben A, Grussendorf-Conen EI. HPV 18-induced pigmented bowenoid papulosis of the neck. J Am Acad Dermatol 1999; 40:633–634 Olhoffer IH, Davidson D, Longley J, et al. Facial bowenoid papulosis secondary to human papillomavirus type 16. Br J Dermatol 1999; 140:761–762 Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265:472–477 Gravitt P, Hakenewerth A, Stoerker J. A direct comparison of methods proposed for use in widespread screening of human papillomavirus infections. Mol Cell Probes 1991; 5:65–72 Greer CE, Peterson SL, Kiviat NB, et al. PCR amplification from paraffin-embedded tissues. Effects offixative and fixation time. Am J Clin Pathol 1991; 95:117–124 Cox JT, Lorincz AT, Schiffman MH, et al. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172:946–954 Lorincz AT, Reid R, Jenson AB, et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79:328–337 Silins I, Wang Z, Avall-Lundqvist E, et al. Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis. J Gen Virol 1999; 80:2931–2936 Park KC, Kim KH, Youn SW, et al. Heterogeneity of human papillomavirus DNA in a patient with Bowenoid papulosis that progressed to squamous cell carcinoma. Br J Dermatol 1998; 139:1087–1091 Fang BS, Guedes AC, Munoz LC, et al. Human papillomavirus type 16 variants isolated from vulvar Bowenoid papulosis. J Med Virol 1993; 41:49–54 Rudlinger R, Grob R, Yu YX, et al. Human papillomavirus-35-positive bowenoid papulosis of the anogenital area and concurrent human papillomavirus-35-positive verruca with bowenoid dysplasia of the periungual area. Arch Dermatol 1989; 125:655–659 Jablonska S, Majewski S. Human papillomaviruses—from trifle warts to cancers of the skin and mucosa. Przegl Dermatol 1998; 85:169–173 Sugase M, Moriyama S, Hata S, et al. Detection of human papillomavirus type 16 DNA and papillomavirusgenus-specific antigens in vulva and cervix from patients with Bowenoid papulosis. Jpn J Cancer Res 1989; 80:19–23 Beaudenon S, Kremsdorf D, Croissant O, et al. A novel type of human papillomavirus associated with genital neoplasias. Nature 1986; 321:246–249 Bocking A, Chatelain R, Salterberg A, et al. Bowenoid papulosis. Classification as a low-gradein situ carcinoma of the epidermis on the basis of histomorphologic and DNA ploidytstudies. Anal Quant Cytol Histol 1989; 11:419–425